A 53-year-old man with a history of pancreatic tail neuroendocrine tumor (PNET) with liver metastasis, since 2014, presented with sudden onset large-volume hematemesis, hypotension, and an acute drop in hemoglobin from 8.7 g to 5.1 g. The patient was transferred to the intensive care unit and received 4 units of blood, 1 unit of platelets, and 1 unit of fresh frozen plasma. Pantoprazole 40 mg intravenously (IV) was given twice daily (BID) IV. A first EGD showed blood clots that precluded adequate visualization of the gastric body (Fig. 1A) . No esophageal varices were seen. A second EGD revealed a large 4-to 5-cm ulcer in the posterior wall of the gastric body, with heaped borders and extension into the deep tissue, suspected to be secondary to metastatic infiltration of the known pancreatic tail neuroendocrine tumor into the gastric wall (Fig. 1B) . No active bleeding or visible vessels were noted. No esophageal or gastric varices were seen. Biopsy specimens were taken. Abdominal magnetic resonance imaging (MRI) showed a poorly defined hyperenhancing mass in the pancreatic tail, which abuts the greater curvature of the stomach and the anterior aspect of the spleen. Multiple centrally necrotic hyperenhancing hepatic masses compatible with metastatic disease were seen (Fig. 1C) .
EUS-guided arterial embolization was performed because the 2 previous endoscopies had failed to identify and control the source of bleeding (Video 1, available online at www.VideoGIE.org). The linear-array EUS was advanced into the gastric body. There was a hypoechoic, ill-defined mass larger than 3 cm in the tail of the pancreas (Fig. 1D) . This lesion appeared to be hypervascularized, and a 2-mm feeding vessel was identified in the inferior portion at the edge of the lesion (Fig. 1E) . It appeared to have arterial-type Doppler flow. Then a 22G FNA needle, prewashed with sterile water, was advanced into the feeding vessel under Doppler flow guidance. Once Written transcript of the video audio is available online at www.VideoGIE.org. adequate needle position was confirmed, 1 mL of cyanoacrylate glue was injected into the feeding vessel, and the needle was then carefully retrieved (Fig. 1F) . Embolization was confirmed with the disappearance of the Doppler flow.
The procedure was well tolerated. Pantoprazole 40 mg IV BID was started before the procedure and maintained afterward. The patient was given clear liquids the next day and advanced to a soft diet 48 hours after the procedure. His hemoglobin remained stable above 8 g. The patient was discharged home. After 3 months of followup, there was no rebleeding. Biopsy specimens taken during the second EGD were positive for synaptophysin immunolabeling, supporting the diagnosis of gastric invasion of the PNET.
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